Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Huntington Ingalls Industries $1 billion senior notes offering
We advised the underwriters on an investment-grade debt offering
Warner Music Group €445 million notes offering
We advised the joint book-running managers and initial purchasers on the high-yield debt offering
Intel $5 billion senior notes offering
We advised the underwriters on an investment-grade notes offering
SVB Financial Group $1.25 billion stock offering
We advised the underwriter on the equity offering
Uber Technologies $1.5 billion senior notes offering
The high-yield offering involved 4.5% notes due 2029
Adagio Therapeutics $356 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Crocs $350 million senior notes offering
We advised the initial purchasers on the high-yield notes offering
GFL Environmental $550 million senior notes offering
We advised the initial purchasers on the high-yield debt offering
Viveo R$1.9 billion IPO
We advised Viveo and the selling shareholders on its IPO and São Paulo Stock Exchange listing
Fujian Yango $250 million high-yield notes offering and cash tender offer
We advised the joint lead managers on the Regulation S senior notes offering and concurrent tender offer